FIELD: pharmacy. SUBSTANCE: invention relates to medicinal form of human recombinant interferon-alpha-2 - rectal and vaginal suppositories. Suppository has indicated interferon, antioxidants - vitamin A, α-tocopherol (vitamin E), hyaluronic acid and butyrum-cacao as base taken at the definite ratio of components. Invention ensures to avoid inconvenience and hazard associated with administration of interferon as injection solutions. EFFECT: improved properties of medicinal form.
| Title | Year | Author | Number |
|---|---|---|---|
| IMPROVED MEDICINAL FORM OF INTERFERON INDUCTOR | 1998 |
|
RU2162687C2 |
| PERORALLY, RECTALLY OR INTRAVAGINALLY INJECTED COMPOSITION CONTAINING ALIVE BACTERIA | 2000 |
|
RU2182008C1 |
| COMPLEX ANTIVIRAL MEDICATION FOR EXTERNAL APPLICATION IN TREATMENT OF HERPES VIRUS INFECTIONS | 2010 |
|
RU2438697C1 |
| AGENT FOR SEVERE INFECTIOUS DISEASES AND MIXED INFECTIONS | 2008 |
|
RU2366450C1 |
| AGENT POSSESSING IMMUNOMODULATORY AND ANTIVIRAL ACTIVITY | 2015 |
|
RU2592201C1 |
| CURATIVE AGENT | 2005 |
|
RU2283133C1 |
| METHOD OF PREPARING ANTIHERPETIC VACCINE AND MEDICINAL FORM BASED ON SAID | 1997 |
|
RU2142816C1 |
| STABILISED IMMUNE-CORRECTIVE DRUG VIFERON-FORTE FOR TREATING INFECTIOUS-INFLAMMATORY DISEASES | 2008 |
|
RU2381812C1 |
| PHARAMCEUTICAL AGENT FOR TREATMENT OF VIRAL AND DIFFERENT INFECTIONS | 2006 |
|
RU2323738C1 |
| IMMUNOMODULATING, ANTIVIRAL, ANTIBACTERIAL, ANTIOXIDATING, MEMBRANE STABILISING, ANTI-INFLAMMATORY, ANTITOXIC MEDICINAL AGENT FOR INFLAMMATORY-INFECTIOUS DISEASES | 2007 |
|
RU2327486C1 |
